TP53 and cancer: MMR-DCF can give rise to (1) cancers developing from intra-mucosal neoplastic lesions after accumulation of mutations in genes such as APC, KRAS or RNF43, and (2) immediately invasive cancers arising from non-polypus lesions through mutations in CTNNB1 or TP53 genes [65].